Α托珠单抗治疗严重甲状腺眼病1例。

Q3 Medicine

Acta medica (Hradec Kralove) Pub Date : 2021-01-01 DOI:10.14712/18059694.2021.12

Aysel Mehmet, Eirini Kanella Panagiotopoulou, Aristeidis Konstantinidis, Charalampos Papagoras, Panagiotis Skendros, Doukas Dardabounis, Athanasia Maria Mikropoulou, Georgios Labiris

引用次数: 3

摘要

这是一个病例报告，描述了一名患有严重甲状腺眼病并甲状腺功能障碍视神经病变的患者，该患者对静脉注射类固醇和眼眶放疗无反应，但静脉注射托珠单抗反应良好。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Α Case of Severe Thyroid Eye Disease Treated with Tocilizumab.

This is a case report describing a patient with severe thyroid eye disease complicated with dysthyroid optic neuropathy that was unresponsive to intravenous steroids and orbital radiotherapy but responded well to intravenous tocilizumab.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Acta medica (Hradec Kralove) Medicine-Medicine (all)

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

20 weeks

期刊介绍： Acta Medica (Hradec Králové) is a multidisciplinary medical journal published by the Faculty of Medicine in Hradec Králové - Karolinum Press, the publishing house of Charles University. The journal is peer-reviewed and published quarterly in both paper and electronic form. The language of Acta Medica is English. Offerings include review articles, original articles, brief communications, case reports, announcements and notices. The journal was founded in 1958 under the title "A Collection of Scientific Works of the Charles University Faculty of Medicine in Hradec Kralove."